Echocardiography Course undertaken at Richmond Pharmacology
Posted:
13
March 2019
Richmond Pharmacology CEO, Dr Jorg Taubel, Franklin Gordon, Resuscitation Simulation & Clinical Skills Practitioner and Dr Simon Coates, Research Physician respectively, all began in-house training...
Echocardiography Course undertaken at Richmond Pharmacology
Richmond Pharmacology CEO, Dr Jorg Taubel, Franklin Gordon, Resuscitation Simulation & Clinical Skills Practitioner and Dr Simon Coates, Research Physician respectively, all began inhouse training for a BSE Level 1 Echocardiography this February.A Level 1 Echocardiography is designed to be accessible to echocardiography practitioners from a wide variety of backgrounds, and has, at its ultimate aim, the achievement and maintenance of high standards of clinical echocardiography to rule out life threatening and immediately reversible pathology in a time frame appropriate to the acute emergency patient.The course will run over a 2-year duration and qualify the individuals for a BSE Level 1 Qualification.
Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations
April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Richmond Pharmacology announces CEO Dr. Jorg Taubel's appointment as President Elect of Germany's AGAH, where he will enhance early-phase clinical research over a six-year term.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.